Dr Adam M Brufsky from the University of Pittsburgh discusses first-line treatment selection for patients with HR-positive metastatic breast cancer and preexisting medical conditions.
CME information and select publications here.
View all episodes
By Dr. Neil Love
4.3
6060 ratings
Dr Adam M Brufsky from the University of Pittsburgh discusses first-line treatment selection for patients with HR-positive metastatic breast cancer and preexisting medical conditions.
CME information and select publications here.
17 Listeners
31 Listeners
15 Listeners
1,009 Listeners
11 Listeners
73 Listeners
0 Listeners
114 Listeners
5,300 Listeners
485 Listeners
43,466 Listeners
192 Listeners
3,503 Listeners
7,916 Listeners
53 Listeners
28,309 Listeners
1,975 Listeners
166 Listeners